Profile and prevalence of aspirin resistance in patients with cardiovascular disease
Top Cited Papers
- 1 August 2001
- journal article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 88 (3) , 230-235
- https://doi.org/10.1016/s0002-9149(01)01631-9
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Prior aspirin use predicts worse outcomes in patients with non–ST-elevation acute coronary syndromesThe American Journal of Cardiology, 1999
- Cyclooxygenase-2 in human platelets as a possible factor in aspirin resistanceThe Lancet, 1999
- CYCLOOXYGENASES 1 AND 2Annual Review of Pharmacology and Toxicology, 1998
- Cyclooxygenases-1 and −2 of Endothelial Cells Utilize Exogenous or Endogenous Arachidonic Acid for Transcellular Production of ThromboxaneJournal of Biological Chemistry, 1996
- Development of aspirin resistance in persons with previous ischemic stroke.Stroke, 1994
- Efficacy of ticlopidine and aspirin for prevention of reversible cerebrovascular ischemic events. The Ticlopidine Aspirin Stroke Study.Stroke, 1993
- Aspirin response and failure in cerebral infarction.Stroke, 1993
- Effects of low-to-high doses of aspirin on platelet aggregability and metabolites of thromboxane A2 and prostacyclin.Stroke, 1992
- Sex difference in antithrombotic effect of aspirin.Stroke, 1989
- Platelet aggregation studies in coronary artery diseaseAtherosclerosis, 1978